Release Date: February 26, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you provide more details on the number of pitches and pipeline with Microsoft, and when these might convert to revenue? A: Thomas Siebel, CEO: We are currently involved in over 600 engagements with Microsoft, where we are the preferred enterprise AI solution. These engagements span across various regions and industries. Since the agreement with Microsoft was signed, we have already closed 28 agreements, indicating a quick conversion to revenue.
Q: Can you discuss the trends in remaining performance obligations and what to expect going forward? A: Hitesh Lath, CFO: At the end of the quarter, our total remaining performance obligations (RPO) were around $208 million. RPO is not a leading indicator of our business, and we expect some decline in RPO in the near term.
Q: Could you elaborate on the health setback mentioned in your February 18 note and its impact on business operations? A: Thomas Siebel, CEO: I experienced flu-like symptoms that developed into an autoimmune disease affecting my optical nerve, impairing my vision. Despite this, I remain fully engaged in managing the business daily, with accommodations in place to assist with tasks like reading emails. Jim Snabe, a distinguished director, is assisting with travel and events I cannot attend.
Q: What drove the outperformance in professional services revenue this quarter? A: Hitesh Lath, CFO: The increase in professional services revenue was due to higher revenue from consulting services, paid implementation services, and training services during the quarter.
Q: Why have demonstration licenses been outperforming recently, and what is driving this trend? A: Thomas Siebel, CEO: The demand for demonstration licenses has increased due to the need to equip our partners, such as Azure and AWS, with complete sales kits, including demonstration software. This enables them to effectively demonstrate our solutions independently, which is crucial for our sales strategy.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.